Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT02516670 · TERMINATED

Trial details

NCT number: NCT02516670
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2016-06-20
Primary completion: 2021-07-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.